• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION REZUM; UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES) Back to Search Results
Model Number D2201
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fistula (1862); Loss of consciousness (2418); Fluid Discharge (2686)
Event Date 08/01/2022
Event Type  Injury  
Manufacturer Narrative
Date of event: the exact event date is unknown.
 
Event Description
It was reported by a physician that he had a patient that was admitted to the hospital where it was discovered that he developed a rectal fistula post water vapor therapy procedure.The patient was discharged from the hospital but was re-admitted to the hospital after being found unresponsive.The physician further reported that he followed the correct protocol.The physician indicated that he did not deploy the delivery device needle straight down into the patient s median lobe but rather aimed at a 45 degree angle.The patient did have a smaller prostate gland.The gland was approximately 30g, and the patient did complain of mucus prior to the procedure.The patient is now being seen by another physician who surgically fixed the patient's fistula which was located toward the apex of the prostate.It is the physician s opinion that the water vapor therapy treatment to the prostate median lobe contributed to the rectal fistula.
 
Event Description
It was reported by a physician that he had a patient that was admitted to the hospital where it was discovered that he developed a rectal fistula following water vapor therapy procedure.The patient was discharged from the hospital but was re-admitted to the hospital after being found unresponsive.The physician further reported that he followed the correct protocol; he indicated that he did not deploy the delivery device needle straight down into the patient's median lobe but rather aimed at a 45 degree angle.The patient did have a smaller prostate gland.The gland was approximately 30g, and the patient did complain of mucus prior to the procedure.The patient is now being seen by another physician who surgically fixed the fistula, located toward the apex of the prostate.The second physician reportedly expressed the opinion that the water vapor therapy treatment to the prostate median lobe contributed to the rectal fistula.Despite good faith efforts, no further information regarding device performance, procedure details, or patient status pre- and post-procedure could be obtained.
 
Manufacturer Narrative
There was no device available for analysis; therefore, no physical or visual analysis of the product could be performed.There is insufficient information to make an adequate assessment on if or how the unresponsive episode which led to another hospitalization is related to the rezum device and/or procedure.The reported patient symptoms of fluid discharge, loss of consciousness, and fistula requiring surgical repair are known risks associated with water vapor therapy procedures and are noted as such in the device instructions for use.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REZUM
Type of Device
UNIT, ELECTROSURGICAL ENDOSCOPIC (WITH OR WITHOUT ACCESSORIES)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer Contact
alyson harris
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key15287520
MDR Text Key298559042
Report Number2124215-2022-32229
Device Sequence Number1
Product Code KNS
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD2201
Device Catalogue NumberD2201
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/03/2022
Initial Date FDA Received08/24/2022
Supplement Dates Manufacturer Received09/19/2022
Supplement Dates FDA Received09/29/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
-
-